Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$0.17 - $4.00
Next Earnings Date
May 13 2025
Next Earnings Date
May 13 2025
Latest price
Market Cap | $47.73M |
EV | $44.59M |
Shares Outstanding | 207.34M |
Beta | 0.16 |
Analyst Rating | HOLD |
Analyst Target Price | $1.00 |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | - |
EPS | 59.80% |
Operating Cash Flow | 24.50% |
Free Cash Flow | 24.40% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Cyclacel Pharmaceuticals, Inc.
CYCC
Sector
Healthcare
Industry
Biotechnology
CEO
Rombotis, Spiro
Employees
12
Website
www.cyclacel.comIPO Date
2004-03-16
Headquarters
200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey, 07922, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved